At an interactive session with distributors of the company, the Executive Director, Pharma Sales & Marketing, Mr. Chukuka Chukutem has disclosed that May & Baker Nigeria Plc has said that it has plans to grow its drug manufacturing and distribution business by 75 per cent in 2017 from a turnover of over N6 billion in 2016. Chukutem has said that the company plans to achieve this through regular product availability, introduction of new products, increased brand support and promotion as well as a well mapped out distributor support and incentive system that would make them grow their businesses. The Managing Director of May & Baker,  Mr. Nnamdi Okafor has said that despite the economic recession the company had over18 per cent turnover growth in 2016 when compared to 2015, averaging 11 per cent increase. During the forum, the company launched a new product, Easadol Suspension, a flavored pain relief for children.

No Comments

Leave a Comment